Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Noni leaf oil (Morinda citrifolia) contains flavonoids and phenolics that demonstrate ABTS scavenging activity of 55.91% and modulate Nrf2/NF-κB pathways. Research shows it reduces LPS-induced nitric oxide production by 10.64% at 400 µg/mL concentration, supporting anti-inflammatory mechanisms.
Reported Benefits (Provisional)
Origin & History
Noni Leaf (Morinda citrifolia) originates from a small evergreen tree native to the tropical coastal regions of Southeast Asia, Australasia, and the Pacific Islands. Thriving in nutrient-rich volcanic soils, the leaves are a traditional source of potent phytochemicals, valued for their detoxifying and immune-supportive properties in functional nutrition.
Research Narrative (Provisional)
Emerging research, including in vitro and animal studies, supports the traditional uses of Noni Leaf, highlighting its antioxidant, anti-inflammatory, and immune-modulating properties. Studies have investigated its potential for skin healing and antimicrobial activity. Further human clinical trials are warranted to confirm these benefits and establish optimal applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin A, Vitamin C, B vitamins (B3, B6). - Minerals: Potassium, Magnesium, Calcium, Iron. - Phytochemicals: Flavonoids (kaempferol, quercetin), Polysaccharides, Carotenoids, Alkaloids, Anthraquinones (damnacanthal, morindone), Iridoids, Terpenes, Phytosterols. - Other: Dietary Fiber.
Reported Mechanism (Provisional)
Noni leaf oil's flavonoids and phenolics upregulate endogenous antioxidant enzymes (SOD, CAT, GPx) through Nrf2/Keap1 pathway modulation. The compounds inhibit COX-2 and 5-LOX enzymes at 0.5-1.0 mg/mL concentrations while suppressing NF-κB-mediated inflammatory responses. Lignans including 3,3′-bisdemethylpinoresinol and americanin A contribute to cytochrome c release and caspase activation in cellular studies.
Clinical Narrative (Provisional)
Current evidence relies primarily on in vitro and animal studies rather than human clinical trials. Topical safety was evaluated in 49 adult volunteers with no adverse effects reported, though this represents limited human data. Animal studies demonstrate enhanced skeletal muscle angiogenesis via VEGFA and improved SOD2/GSH levels during exercise performance models. The 2023 comprehensive review emphasizes the need for large-scale randomized controlled trials to establish clinical efficacy and safety profiles.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.